Vitrakvi: Presence Of Contamination In Affected Lot

Vitrakvi Recall Summary Vitrakvi, a prescription cancer medication, is being recalled in Canada due to contamination found in certain lots. This is a Class I recall, which indicates a serious health risk. The affected product was distributed across Canada.

Product
Vitrakvi
Reason
Contamination
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2023-11-08
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/4a04b86a-aeef-4976-a779-c0e6cb5012c6